Proud Euan, Mueller Tanja, Gronkowski Karen, Kurdi Amanj, Platt Niketa, Morrison Aidan, Bennie Marion, Malcolm William
Public Health Scotland Glasgow Office, Glasgow, UK
Pharmacy, NHS Forth Valley, Stirling, UK.
Eur J Hosp Pharm. 2025 Apr 23;32(3):232-235. doi: 10.1136/ejhpharm-2023-003874.
The Access, Watch and Reserve (AWaRe) list of antibiotics was developed by the WHO to support antibiotic stewardship programmes (ASP). The Access group incorporates first-line options, while Watch antibiotics have higher resistance potential or toxicity, and Reserve drugs should be used only for complex infections. ASP implementation has been challenged during the COVID-19 pandemic. There is a knowledge gap regarding in-hospital prescribing patterns of antibiotics nationally during the COVID-19 pandemic, and on the characteristics of hospitalised patients prescribed antibiotics during this time. We aimed to evaluate quality of antibiotic use according to AWaRe classification in Scottish hospitals, including assessing the impact of COVID-19 on trends.
Cross-sectional study of antibiotics prescribed to hospitalised patients from 1 January 2019 to 30 June 2022 in a selection of Scottish hospitals, covering approximately 60% (3.6 million people) of the Scottish population. Data were obtained from the Hospital Electronic Prescribing and Medicines Administration system. Prescribing trends were explored over time, by age and by sex.
Overall, a total 1 353 003 prescriptions were identified. An increase in Access antibiotics was found from 55.3% (31 901/57 708) to 62.3% (106 449/170 995) over the study period, alongside a decrease in Watch antibiotics from 42.9% (24 772/57 708) to 35.4% (60 632/170 995). Reserve antibiotic use was limited throughout, with minor changes over time. Changes in prescribing were most pronounced in the older age group (>65 years): proportions of Access antibiotics increased from 56.4% (19 353/34 337) to 65.8% (64 387/97 815, p<0.05), while Watch antibiotics decreased from 41.9% (14 376/34 337) to 32.3% (31 568/97 815, p<0.05) between Q1 2019 and Q2 2022. Differences between males and females were insignificant.
Findings showed encouraging trends in Access and Watch use among hospitalised patients, in line with Scottish national standards. There was no noteworthy effect of COVID-19 on prescribing trends despite reports indicating stewardship programmes being negatively impacted by the pandemic.
世界卫生组织制定了抗生素获取、监测与储备(AWaRe)清单,以支持抗生素管理计划(ASP)。“获取”类包括一线用药选择,“监测”类抗生素具有较高的耐药性或毒性,“储备”类药物仅应用于复杂感染。在新冠疫情期间,ASP的实施面临挑战。关于新冠疫情期间全国医院内抗生素的处方模式,以及在此期间使用抗生素的住院患者特征,存在知识空白。我们旨在根据AWaRe分类评估苏格兰医院抗生素的使用质量,包括评估新冠疫情对趋势的影响。
对2019年1月1日至2022年6月30日期间苏格兰部分医院住院患者使用的抗生素进行横断面研究,覆盖约60%(360万人)的苏格兰人口。数据来自医院电子处方和药品管理系统。按时间、年龄和性别探讨处方趋势。
总体而言,共识别出1353003张处方。在研究期间,“获取”类抗生素的使用比例从55.3%(31901/57708)增至62.3%(106449/170995),同时“监测”类抗生素的使用比例从42.9%(24772/57708)降至35.4%(60632/170995)。“储备”类抗生素的使用一直有限,且随时间变化较小。处方变化在老年组(>65岁)最为明显:2019年第一季度至2022年第二季度期间,“获取”类抗生素的比例从56.4%(19353/34337)增至65.8%(64387/97815,p<0.05),而“监测”类抗生素从41.9%(14376/34337)降至32.3%(31568/97815,p<0.05)。男性和女性之间的差异不显著。
研究结果显示,住院患者在“获取”类和“监测”类抗生素的使用方面呈现出令人鼓舞的趋势,符合苏格兰国家标准。尽管有报告表明管理计划受到疫情的负面影响,但新冠疫情对处方趋势没有显著影响。